MSB 7.69% $1.19 mesoblast limited

Ann: Mesoblast Update on COVID-19 ARDS Trial, page-339

  1. 405 Posts.
    lightbulb Created with Sketch. 39
    CLBP - cost/benefit ratio for such an expensive treatment. Not sure it will ever get FDA. What is the cost of treatment...CLBP has significant impact on quality of life, but not sure insurance companies would be willing to reimburse the costs. I had hopes for ARDS trial but i feel they stuffed the trial design
    Hugely disappointed. Enjoy your R&R
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.19
Change
0.085(7.69%)
Mkt cap ! $1.358B
Open High Low Value Volume
$1.10 $1.20 $1.09 $13.21M 11.37M

Buyers (Bids)

No. Vol. Price($)
1 15000 $1.19
 

Sellers (Offers)

Price($) Vol. No.
$1.19 75212 5
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.